These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 23951819

  • 1. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
    Unsematham S, Kateruttanakul P.
    J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
    [Abstract] [Full Text] [Related]

  • 2. Drug resistance among new smear-positive pulmonary tuberculosis cases in Thailand.
    Kateruttanakul P, Unsematham S.
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):814-7. PubMed ID: 23676168
    [Abstract] [Full Text] [Related]

  • 3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S, Kumar A, Kapoor SK.
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [Abstract] [Full Text] [Related]

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 5. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [Abstract] [Full Text] [Related]

  • 6. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H, Kant S, Jain A, Natu SM, Ahluwalia S.
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [Abstract] [Full Text] [Related]

  • 7. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 8. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [Abstract] [Full Text] [Related]

  • 9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 10. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A, Aung KJ, Hossain MA, Van Deun A.
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [Abstract] [Full Text] [Related]

  • 11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 12. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R, Nataraj G, Kanade S, Khatri V, Mehta P.
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [Abstract] [Full Text] [Related]

  • 13. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS, Kumar AM, Claassens M, Banurekha VV, Sekar G, Venkatesan P, Swaminathan S.
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [Abstract] [Full Text] [Related]

  • 14. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 15. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y, Yue W, Chen X, Liang B, Gong F, Du J.
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [Abstract] [Full Text] [Related]

  • 16. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [Abstract] [Full Text] [Related]

  • 17. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D, Bechan S, Connolly C, Standing E, Short GM.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Jan; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

  • 19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, Thyagarajan K, Selvakumar N, Adhilakshmi AR, Iliayas S, Narayanan PR.
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [Abstract] [Full Text] [Related]

  • 20. Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout.
    Aung KJ, Declercq E, Ali MA, Naha S, Datta Roy SC, Taleb MA, Hossain MA, Rigouts L, Gumusboga A, Van Deun A.
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):455-61. PubMed ID: 22640511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.